论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
SARS-CoV-2 感染后 “急性黄斑神经视网膜病变” 患者数量短暂增加:2022 年 12 月第一次感染激增期间的病例系列
Authors Xu B, Zhang J, Zhang Y, Cheng Y, Huang Q
Received 24 April 2023
Accepted for publication 15 June 2023
Published 3 July 2023 Volume 2023:16 Pages 2763—2771
DOI https://doi.org/10.2147/JIR.S413050
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Ning Quan
Objective: Acute macular neuroretinopathy (AMN) has been associated with several conditions. The aim of this study is to report a surge of AMN cases diagnosed since the easing of epidemic control for COVID-19 in China, in early December 2022.
Case Report: Four cases presented with paracentral or central scotomas, or blurred vision soon after SARS-CoV-2 coronavirus infection. Fundus manifestations were recorded, including typical hyper-reflective segments of the outer plexiform layer (OPL) and outer nuclear layer (ONL), and associated disruption of ellipsoid, interdigitation zones, and retinal pigment epithelium (RPE) layers on optical coherence tomography (OCT). Oral prednisone was administered and gradually tapered. Slight scotoma persisted with hyper-reflective segments fading and irregularity of outer retina on OCT during the follow-up. Case 4 was lost to follow-up.
Conclusion: With the ongoing pandemic and extensive vaccination programs, it is expected that cases of AMN will surge. It is important for ophthalmologists to be aware of the possibility of COVID-19-induced AMN.
Keywords: AMN, COVID-19, OCT, retina, SARS-CoV-2